EUCTR2012-002469-37-IT进行中（未招募）不适用
Phase II clinical study on the efficacy and safety of procedural analgesia of oral transmucosal fentanyl citrate in oncologic patients eligible to permanent central venous catheter
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) patients > 18 years
- •2) Histologically confirmed diagnosis of cancer
- •3) Eligibility to permanent central venous catheter
- •4) Absence of cognitive impairment
- •5) ability to give informed consentg
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 45
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •1)patients alreday treated with oppioids due to chronic oncologic pain
- •2)patients with previous nausea or vomiting due to oppioid treatment
- •3)patients with previous intolerance to fentanyl e.v. or transmucosal
- •4)chronic respiratory failure
- •5)renal or hepatic impairment
研究者
相似试验
招募中
2 期
Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapyJPRN-UMIN000010055Respiratory Center, Showa University Northern Yokohama Hospital20
进行中（未招募）
1 期
Phase II clinical trial to evaluate safety and efficacy of mobilisation and collection of CD34+ cells after treatment with plerixafor and filgrastim in patients with Fanconi anaemia for subsequent transduction with a lentiviral vector carrying the FANCA gene and reinfusion into the patient - Fancostem-Plerixafor & Filgrastim mobilisation in Fanconi AnaemiaEUCTR2014-004272-29-GBGreat Ormond Street Hospital NHS foundation Trust20
招募中
2 期
Phase II study of multimodality treatment for ATRTAtypical teratoid rhabdoid tumorD016543JPRN-jRCTs051200071Junichi Hara50
招募中
2 期
Phase II study of new risk classification and high-dose chemotherapy for medulloblastomaJPRN-jRCTs051200021Hara Junichi229
尚未招募
2 期
Phase II study to evaluate the efficacy and safety of mirogabalin for CIPN in patients with gastrointestinal cancer.esophageal cancer, gastric cancer, small bowel cancer, colon cancer, pancreatic cancerJPRN-UMIN000049555ational Cancer Center Hospital30